Tag: Codexis
Codexis lowers losses to $9.6 million for Q1 2013
Tweet In California, Codexis reports revenues for the first quarter of 2013 were $11.5 million, a 45% increase from $7.9 million in the fourth quarter of 2012. Net operating costs were $21.1 million, a nearly 11% decrease from the fourth quarter of 2012. The net loss was $9.6 million, or a loss of $0.25 per [...]
Shaw turns back on cellulosic and dives into natgas
Tweet In California, former CEO of Codexis and current CEO of Calysta Energy Alan Shaw now says that it’s not economical to produce next generation fuels from crops, so has switched to natural gas as feedstock. He says that falling gas prices thanks to shale gas to funneling funds that had been going to biofuel [...]
Who’s ahead now in enzymes? Codexis launches Next-Gen CodeXyme4
Tweet Compared to prior generations, CodeXyme 4 and CodeXyme 4X significantly reduce the cost of cellulosic sugar production for biofuels and bio‐based chemicals. In California, Codexis announced the launch of CodeXyme 4 and CodeXyme 4X cellulase enzyme packages for use in producing cellulosic sugar for production of biofuels and bio‐based chemicals. Codexis’ latest generation of [...]
Strem and Codexis sign enzyme distribution agreement
Tweet In Massachusetts, Strem Chemicals and Codexis have signed an enzyme distribution agreement, in which Strem receives exclusive distribution rights for the new 100mg CODEX Screening Kits for Codexis’ popular Transaminase and Ketoreductase enzyme platforms. These enzymes enable efficient conversion of ketones to chiral alcohols or amines. The screening kits contain enzymes evolved with proprietary [...]
Codexis handily beats Street consensus in Q3 earnings
Tweet In California, Codexis, reported revenues for the third quarter of 2012 of $26.3 million, a 21% decrease from $33.3 million in the third quarter of 2011. Product revenue in the third quarter of 2012 was $7.1 million, a 41% decrease from $12.2 million in the prior year quarter and a 5% sequential increase from [...]
Biofuels Digest releases new 5-Minute Guides: Sapphire Energy, Algenol, Codexis
Tweet Biofuels Digest has released the next wave of its 5-Minute Guides – a “news you can use” digest on the leading companies in biofuels. Each 5-Minute Guide provides a company description, 3 top milestones for 2010-12 and projected for 2012-14, description of the business model; plus project info (location, feedstocks, product set, processing technology, [...]
Codexis: Biofuels Digest’s 5-Minute Guide
Tweet Address: 200 Penobscot Drive Redwood City, CA 94063 Year founded 2002 Annual Revenues: $107 million (2010) Company description: Codexis serves major worldwide markets where clean technology can make a positive economic and environmental impact. Codexis CodeEvolver ™ directed evolution technology accelerates development of high value sustainable products. Our focus is on the cost-effective conversion [...]
Codexis, Shell redraw the advanced biofuels map with global enzyme rights deal
Tweet Codexis, Shell redefine relationship; Codexis gains global rights; will lay off 133 staff; adopts anti-takeover measures; what does it mean for Shell, Raizen, Iogen, Codexis and Dyadic? What does it say about strategic investors in advanced biofuels? In California, Codexis announced that Shell has granted Codexis a royalty-bearing, non-exclusive license to develop, manufacture, use [...]
On the Move in Biofuels: Codexis, LS9 add CFOs
Tweet In California, Codexis announced the appointment of David O’Toole as Senior Vice President and Chief Financial Officer, effective September 4, 2012. O’Toole served most recently as Vice President and Chief Financial Officer at Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer and analytical testing services [...]
Codexis announces new deal with Shell, slashes 133 employees
Tweet In California, Codexis announced that the company has signed an agreement with Shell to expand Codexis’ ability to commercialize its CodeXymeTM cellulase enzymes under a royalty-bearing, non-exclusive license to develop, manufacture, use and sell cellulase enzymes developed according to the companies’ Amended and Restated Collaborative Research Agreement. It also announced a workforce reduction as part [...]
